Metformin Dosage, half-life & reference guide

Also known as Glucophage · Metformin hydrochloride · Metformin ER · Glumetza · Fortamet · Riomet

Reviewed Evidence: ModeratePublished by PepVault

The first-line type 2 diabetes drug, cheap and used for decades, which lowers blood sugar mainly by quieting the liver's glucose output. It became a longevity candidate when diabetics on it seemed to outlive people without diabetes, but a larger study found they did not, and mice in the NIA's program did not live longer on it alone. It does prevent diabetes in people at high risk.

Studied range
500–1000 mgstarting dose 500 mg
How often
2× daily
Half-life
~6.2 hours
Evidence
●●● Moderate
Route
Oral tablet

Studied in research — not a recommendation. FDA-approved for type 2 diabetes; longevity use is off-label.

How it works.

Metformin lowers blood sugar mainly by making the liver release less glucose, and it improves how the body responds to insulin. In cells it is thought to work through energy sensing (AMPK) and a mild brake on mitochondria, the same pathways aging research points to. The longevity case grew from diabetes data: people on metformin seemed to live as long as people without diabetes. Since then, a larger Danish study found they did not, the NIA's mice did not live longer on metformin alone, and in older adults it blunted the gains from exercise. The trial meant to test it against aging (TAME) has not reported.

Commonly reported: Loose stools in the first weeks, which settle as the dose climbs slowly.

Your report

Taken Metformin? What did you notice?

One tap to start. About 30 seconds, no account.

A smiling woman with silver hair in a grey training top by a window, holding her phone

PepVault for iPhone

Track metformin in PepVault

Log each dose and keep your schedule and step-ups in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Week by week.

What to expect in the first 8 weeks

Onset
Days (blood sugar); the stomach adjusts over 1–3 weeks
Peak effect
Weeks to months (HbA1c)
Duration
Ongoing; the Diabetes Prevention Program followed people for about 3 years
  1. Day 1–21Clinical

    The first weeks are about the stomach

    Loose stools, nausea and gas are the common start, and why the dose climbs slowly with meals. For most people they ease within a few weeks.

    The science

    FDA label: most common adverse reactions (> 5%) are diarrhea, nausea/vomiting, flatulence, asthenia, indigestion, abdominal discomfort and headache; diarrhea led 6% to stop in the US trial. The label starts at 500 mg twice a day or 850 mg once a day with meals and raises it by 500 mg weekly or 850 mg every two weeks, to at most 2,550 mg a day.

    Sources
    • FDA label, metformin tablets (2026)

    Updated Nov 2026

  2. Day 21–120RCT

    Training gains can come in smaller

    In older adults, metformin trimmed what exercise built: less muscle from strength training and smaller fitness gains from cardio, against placebo. Anyone training for muscle or fitness has a reason to weigh that with a clinician.

    The science

    Walton 2019 (MASTERS, NCT02308228): 94 healthy adults aged 65+, 1,700 mg a day or placebo through 14 weeks of progressive resistance training; placebo gained more lean body mass (p = .003) and thigh muscle (p < .001), with a trend to smaller strength gains. Konopka 2019: 53 older adults, 12 weeks of aerobic training; metformin blunted the gains in insulin sensitivity and VO2 max and abolished the rise in muscle mitochondrial respiration.

    Sources
    • Walton et al. (MASTERS) (2019)
    • Konopka et al. (2019)

    Updated Nov 2026

  3. Any dayRCT

    What metformin is built on

    As a diabetes drug, decades of trials. As a longevity drug, the case is weaker than its fame: the survival signal in diabetics did not hold in a larger study, mice did not live longer on it alone, and TAME, the trial meant to settle it, has not reported.

    The science

    Bannister 2014 (UK CPRD, 78,241 metformin users): longer adjusted survival than matched people without diabetes (survival time ratio 0.85 for the controls). Keys 2022 (Danish registers, singletons and discordant twins): metformin-treated type 2 diabetes had higher mortality than no diabetes (adjusted IRR 1.32; twins 1.64). ITP: metformin at 0.1% of diet did not significantly extend lifespan (Strong 2016); a re-analysis with the Gehan test found a gain in males only (Jiang 2024). TAME was proposed in 2016 (Barzilai 2016); ClinicalTrials.gov held no TAME record on Nov-19, 2026, and no results are published.

    Sources
    • Bannister et al. (2014)
    • Keys et al. (2022)
    • Strong et al. (2016)
    • Jiang et al. (2024)
    • Barzilai et al. (2016)

    Updated Nov 2026

  4. With Semaglutide, Semaglutide (oral), Tirzepatide and LiraglutideRCT

    The usual partner of a GLP-1 in diabetes

    In type 2 diabetes, GLP-1 drugs are routinely added on top of metformin; many of their trials enrolled people already taking it. The two lower blood sugar in different ways, and both can upset the stomach at first.

    The science

    Rodbard 2019 (PIONEER 2): 822 people with type 2 diabetes uncontrolled on metformin, oral semaglutide 14 mg or empagliflozin added for 52 weeks; HbA1c −1.3% vs −0.9% at week 26, weight −4.7 vs −3.8 kg at 52 (trial product). The metformin label names a higher risk of low blood sugar only with insulin or insulin secretagogues.

    Sources
    • Rodbard et al. (PIONEER 2) (2019)
    • FDA label, metformin tablets (2026)

    Updated Nov 2026

  5. With RapamycinAnimal

    A blood-sugar partner for rapamycin

    Rapamycin can raise blood sugar, and metformin lowers it. In the NIA's mice the pair extended life in both sexes, more than rapamycin alone did in males. The pair has not been tested for aging in people.

    The science

    Strong 2016 (ITP): metformin (0.1%) with rapamycin (14 ppm) robustly extended lifespan by historical comparison; Jiang 2025 gives +23.6% (females) and +21.2% (males) median from 9 months, while metformin alone had no significant effect by the log-rank test.

    Sources
    • Strong et al. (2016)
    • Jiang et al. (2025)

    Updated Nov 2026

After week 8

  1. Day 120+RCT

    Fewer people tip into diabetes

    Where metformin's long-term benefit is proven is in people heading toward diabetes: over about three years it cut new cases by nearly a third. Diet and activity did more, cutting them by more than half. Over years it can lower vitamin B12, which a blood test checks.

    The science

    Knowler 2002 (Diabetes Prevention Program): 3,234 people without diabetes but with raised fasting and post-load glucose (mean age 51, BMI 34) were assigned placebo, metformin 850 mg twice daily or a lifestyle program; over 2.8 years, diabetes incidence was 11.0, 7.8 and 4.8 per 100 person-years, metformin −31% (95% CI 17–43%), lifestyle −58%. FDA label: metformin may lower B12; measure hematological parameters annually.

    Sources
    • Knowler et al. (DPP) (2002)
    • FDA label, metformin tablets (2026)

    Updated Nov 2026

Day 1 is the day you start it.

FDA label (metformin tablets, DailyMed Nov 2026); the Diabetes Prevention Program and exercise RCTs; observational survival cohorts; the NIA ITP mouse papers. No trial has tested it against aging itself.

Moderate evidence

A typical run.

Run notes

Cycle
Taken every day. The label raises the dose by 500 mg a week (or 850 mg every two weeks) from the starting dose, to fit tolerance.Community practice — opinions vary. Not a clinical recommendation.
Timing
With meals, per the label, which eases the stomach side effects.
Route
Oral tablet
Stacks
Rapamycin, Berberine, Semaglutide

Track it in the app

Safety.

Common side effects

  • Diarrhea
  • Nausea
  • Gas and indigestion
  • Stomach discomfort
  • Lower vitamin B12 over years

Interactions

The label names a higher risk of low blood sugar with insulin or sulfonylureas, a higher lactic-acidosis risk with drugs such as topiramate, and a pause around iodinated contrast scans in some people. Alcohol adds to its effect on lactate. Discuss every medication with your clinician.

Safety notes

A prescription drug, approved for type 2 diabetes; use for aging is off-label. The label starts at 500 mg twice a day (or 850 mg once) with meals and goes up step by step to at most 2,550 mg a day, which keeps the stomach side effects down. Its boxed warning is lactic acidosis, rare but serious, with risk rising with kidney impairment, age over 65, heavy alcohol, contrast scans, surgery and liver disease; it is not used when kidney function (eGFR) is below 30. Over years it can lower vitamin B12, which the label suggests checking. In older adults it blunted muscle gains from strength training and fitness gains from aerobic training. Discuss with your clinician.

Questions people ask.

What is Metformin?

The first-line type 2 diabetes drug, cheap and used for decades, which lowers blood sugar mainly by quieting the liver's glucose output. It became a longevity candidate when diabetics on it seemed to outlive people without diabetes, but a larger study found they did not, and mice in the NIA's program did not live longer on it alone. It does prevent diabetes in people at high risk.

How is Metformin dosed in research?

The research range for Metformin is 500–1000 mg, twice daily, with meals, with a 500 mg starting dose. Studied in research — not a recommendation. FDA-approved for type 2 diabetes; longevity use is off-label.

How long does Metformin last?

The half-life of Metformin is ~6.2 hours (plasma elimination half-life, FDA label); longer with reduced kidney function and in older adults.

What do people report on Metformin?

Commonly reported on Metformin: loose stools in the first weeks, which settle as the dose climbs slowly.

Is Metformin safe?

The research basis for Metformin is moderate: animal studies + some human data. Common side effects in the library: diarrhea, nausea, gas and indigestion, stomach discomfort and lower vitamin B12 over years.

What does Metformin stack with?

Common stacks for Metformin: Rapamycin, Berberine and Semaglutide.

Track it in the app

Research.

The literature

Search the latest research

Reference.

Cadence

2× daily

Twice daily, with meals

Half-life

~6.2 hours

~6.2 hours (plasma elimination half-life, FDA label); longer with reduced kidney function and in older adults

Research basis

●●● Moderate

Animal studies + some human data

PepVault for iPhone

Track metformin in PepVault

Log each dose and keep your schedule and step-ups in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo

Reviewed How we check the library